Workshop
Understanding HER2 Low Breast Cancer
Event Date
Tuesday, June 02, 2026
1:30 PM - 2:30 PM ET
Presented in Collaboration with:
- Advanced Practitioner Society for Hematology and Oncology APSHO
- American Cancer Society
- American Psychosocial Oncology Society
- American Society of Clinical Oncology
- Association for Molecular Pathology
- Black Womens Health Imperative
- The Breast Cancer Research Foundation
- BreastCancerTrials.org
- Cancer Justice
- Cancer Nation
- Caregiver Action Network
- Intercultural Cancer Council
- Joe's House
- The LGBT Cancer Project
- Living Beyond Breast Cancer
- National Comprehensive Cancer Network NCCN NCCN Guidelines for Patients
- The National Witness Project Inc
- NeedyMeds
- Prevent Cancer Foundation
- Redes en Accion The National Latino Cancer Research Network
- Research Advocacy Network
- Scott Hamilton CARES Foundation
- SHARE Cancer Support
- Sharsheret - The Jewish Breast and Ovarian Cancer Community
- The Sister Study
- Sisters Network Inc - A National African American Breast Cancer Survivorship Organization
- Tigerlily Foundation
- TOUCH The Black Breast Cancer Alliance
- Young Survival Coalition
This activity is supported by an educational grant from Daiichi Sankyo and was made possible through an independent grant from Merck & Co., Inc. CancerCare’s application for continuing education credits for this program is supported by the Diana Napoli Fund.
Topics Covered
- Overview of HER2 Low Breast Cancer, Including What is HER2 Status
- Diagnostic Testing: What is an Immunohistochemistry (IHC) Test or Fluorescence In Situ Hybridization (FISH) Test
- The Role of the Pathologist
- The Role of the Genetic Counselor
- Standard Treatment Options, Including Targeted Therapy
- How Biomarker Testing Informs Treatment Decisions
- New Targeted Treatments
- Updates on Investigational New Drugs in Clinical Trials: How Research Contributes to Treatment Options
- What’s New in the Prevention & Management of Treatment Side Effects, Symptoms, Discomfort & Pain
- Key Questions to Ask Your Health Care Team About Quality-of-Life Concerns for HER2 Low Breast Cancer
- Questions for Our Panel of Experts
Facilitators
Facilitator
Facilitator
Facilitator
Facilitator
Continuing Education Credits
Live Only
Social Workers: This program has been submitted to The University of Texas MD Anderson Cancer Center, an approved provider through the Texas State Board of Social Work Examiners, provider #CS4607, for 1.0 Contact Hour.
Cancer Care, Inc. is recognized by the New York State Education Department’s State Board for Social Work as an approved provider of continuing education for licensed social workers #SW-0088. This workshop is approved for 1.0 Contact Hour.
Certified Health Education Specialists (CHES®): This program is designated for Certified Health Education Specialists (CHES®) and/or Master Certified Health Education Specialists (MCHES®) to receive up to 1 total Category I continuing education contact hour. Cancer Care, Inc is a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc.
To request continuing education paperwork, please email your name, profession, and address to [email protected] after the program. All paperwork for continuing education credit must be requested, completed, and submitted within two weeks of the live program.